
Jim Cramer's Mad Money TV Program, Thursday, May 24. Sell Block: Best Buy ( BBBY ), First Solar ( FSLR ), Mako Surgical ( MAKO ), Deckers ( DECK ), Fossil ( FOSL ) , J.C. Penney ( JCP ) Cramer discussed 6 value traps to avoid: Best Buy
Hosting ( RAX ), Fossil ( FOSL ), Bed, Bath and Beyond ( BBBY ), Ralph Lauren ( RL ), Vitamin Shoppe ( VSI ), Mako Surgical ( MAKO ), Amazon ( AMZN ) Early in the day, the Dow did a nosedive of 198 points, only to close down just 76 points
(Reuters) - Mako Surgical Corp lost a third of its market value on Tuesday after the orthopedic device maker posted disappointing quarterly results and lowered its sales forecast for a key product.
still too early to tell. S&P futures are -0.4% . Some stocks are getting hammered following earnings, including Fossil ( -25% ) and MAKO ( -30% ), while EA is a relatively mild -4.3% . Later : Fed's Fisher Post your comment!
probably knew that this day was coming -- highly-valued MAKO Surgical ( MAKO ) disappointed the Street with its quarterly results ..... are going to be severe. Only zealots believed that MAKO would grow with no interruptions or stumbles, and while
By Bret Jensen : Mako Surgical ( MAKO ) reported earnings after the bell on Monday. The report deeply ..... and issued guidance that was significantly under expectations. MAKO sells similar products to the same customer base as Intuitive Surgical
(Reuters) - MAKO Surgical Corp cut its annual sales projections for a key product as the medical device maker sold fewer-than-expected numbers of its RIO robotic surgery systems in the first...
May 7 (Reuters) - MAKO Surgical Corp cut its annual sales projections for a key product as the medical device maker sold fewer-than-expected numbers of its RIO robotic surgery systems in the first quarter, s en ding its shares down 30 percent after the bell.
MAKO Surgical ( MAKO ): Q1 EPS of -$0.28 misses by $0.08 . Revenue of $19.6M (+50.7% Y/Y) misses by $4M . Shares -27.6% AH. ( PR ) Post your comment!
Shares of Mako Surgical ( MAKO ) are down hard in post-session trade after the company misses Q1 estimates across the board. The company reported a loss of -$0.28 per share on revenue of $19M. Consensus estimates were for an EPS loss of